# SNAPIN Gene: Structure, Function, and Clinical Significance
## Key Takeaways
- SNAPIN is a crucial cytoplasmic adaptor protein involved in vesicular trafficking, SNARE complex assembly, and retrograde axonal transport, with its dysfunction linked to a severe prenatal-onset neurodevelopmental disorder due to biallelic deleterious variants.
- The protein's structure features an N-terminal coiled-coil domain for homodimerization and dynein interaction, a central SNARE-binding domain for SNAP-25 and syntaxin-1, and a C-terminal domain interacting with the BLOC-1 complex, with phosphorylation at S117 and T120 modulating its function.
- SNAPIN plays a vital role in neuronal function by stabilizing the SNARE complex for synaptic vesicle exocytosis, facilitating BDNF-TrkB retrograde axonal transport essential for neuronal survival, and regulating BACE1 trafficking to lysosomes for degradation, thereby impacting Alzheimer's disease pathology.
- Beyond neuroscience, SNAPIN is implicated in cancer biology, notably promoting hepatocellular carcinoma progression by inhibiting ferroptosis via KEAP1 degradation and NRF2 stabilization, and interacts with viral proteins of HCMV and PRRSV, suggesting roles in host-pathogen interactions.
- Pathogenic variants in SNAPIN cause a severe neurodevelopmental disorder characterized by brain malformations, while its dysregulation is associated with Parkinson's disease (via LRRK2 phosphorylation), Alzheimer's disease (via BACE1 trafficking), and schizophrenia (via dysbindin interaction).
---
## Executive Summary & Key Metadata
SNAPIN (SNAP-associated protein) is a ubiquitously expressed, 15 kDa cytoplasmic protein that functions as a critical adaptor at the interface of vesicular trafficking, SNARE complex assembly, and retrograde axonal transport. Initially identified as a SNAP-25 (synaptosomal-associated protein 25) binding partner, SNAPIN has emerged as a pleiotropic regulator of synaptic vesicle release, endolysosomal trafficking, autophagy, and neurotrophin signaling. Its role extends beyond the nervous system into cancer biology, viral replication, and renal physiology. Biallelic deleterious variants in SNAPIN cause a severe prenatal-onset neurodevelopmental disorder characterized by brain malformations, underscoring its non-redundant role in human neurodevelopment [1].
| Attribute | Detail |
|---|---|
| **HGNC Symbol** | SNAPIN |
| **UniProt Accession** | O95295 |
| **Representative PDB ID** | True (multiple structures available; see Section 2) |
| **Chromosomal Locus** | 1p36.31 (GRCh38: chr1: 15,312,000–15,315,000) |
| **Primary Molecular Function** | SNARE complex assembly; retrograde dynein-mediated transport adaptor; BLOC-1 subunit |
| **Disease & Pathology Associations** | Prenatal-onset neurodevelopmental disorder (biallelic variants); hepatocellular carcinoma; schizophrenia (indirect via dysbindin); Parkinson's disease (via LRRK2 phosphorylation); Alzheimer's disease (via BACE1 trafficking) |
---
## 1. Genomic Locus, Chromosomal Organization & Isoforms
### 1.1 Chromosomal Localization and Gene Structure
The human SNAPIN gene is located on the short arm of chromosome 1 at band p36.31, a gene-dense region frequently implicated in neurodevelopmental disorders and tumor suppression. The gene spans approximately 3.2 kilobases of genomic DNA on the plus strand (GRCh38/hg38: chr1:15,312,456–15,315,689). The genomic architecture is compact, comprising five exons and four introns, with the coding sequence distributed across exons 1–5. The primary transcript produces a 410-nucleotide open reading frame encoding a 136-amino acid protein with a predicted molecular mass of 14.9 kDa and an isoelectric point of 5.2.
The promoter region of SNAPIN lacks a canonical TATA box but contains a high-density CpG island spanning the proximal promoter and exon 1, characteristic of housekeeping genes with broad tissue expression. In silico promoter analysis predicts binding sites for the transcription factors SP1, E2F1, and members of the ETS family, consistent with constitutive expression across all adult and fetal tissues examined. The 3' untranslated region (UTR) contains multiple AU-rich elements (AREs) and a conserved microRNA seed sequence for miR-34a, suggesting post-transcriptional regulation that may be relevant in the context of cellular stress and oncogenic transformation.
### 1.2 Alternative Splicing and Isoforms
While SNAPIN is generally considered to have a single predominant protein-coding transcript, high-throughput RNA sequencing (RNA-seq) data from the Genotype-Tissue Expression (GTEx) project reveal two minor alternatively spliced isoforms:
1. **SNAPIN-201 (canonical)**: Comprises all five exons; encodes the full-length 136-amino acid protein (UniProt O95295-1).
2. **SNAPIN-202**: Retains intron 2, introducing a premature termination codon. This transcript is predicted to undergo nonsense-mediated decay (NMD) and is expressed at very low levels in the brain and testis. Its biological significance, if any, remains unknown.
No evidence exists for tissue-specific isoforms with altered C-terminal domains, suggesting that the functional diversity of SNAPIN arises primarily from post-translational modifications and differential protein-protein interactions rather than from alternative splicing.
### 1.3 Regulatory Elements and Enhancer Architecture
Chromatin immunoprecipitation sequencing (ChIP-seq) data from the ENCODE project identify a putative enhancer element approximately 15 kb upstream of the SNAPIN transcription start site, marked by H3K27ac and H3K4me1 histone modifications in neural progenitor cells. This enhancer contains binding motifs for the neurogenic transcription factors NEUROD1 and ASCL1, potentially explaining the elevated SNAPIN expression observed in differentiated neurons relative to proliferating progenitors. Additionally, a CTCF (CCCTC-binding factor) insulator element at the 3' end of the gene demarcates a topological associating domain (TAD) boundary, separating SNAPIN from the neighboring gene encoding the E3 ubiquitin ligase UBE4B.
---
## 2. 3D Protein Domain Architecture & Structural Biology
### 2.1 Primary Sequence and Domain Boundaries
The SNAPIN protein (UniProt O95295) is a small, predominantly α-helical protein with no intrinsic enzymatic activity. Its function is entirely mediated through protein-protein interactions. The primary sequence can be divided into three functional regions:
| Region | Residues | Structural/Functional Features |
|---|---|---|
| **N-terminal region** | 1–40 | Coiled-coil domain; mediates homodimerization and interaction with dynein intermediate chain (DIC) |
| **Central region** | 41–90 | SNARE-binding domain; interacts with SNAP-25, syntaxin-1, and synaptobrevin-2 |
| **C-terminal region** | 91–136 | BLOC-1 interaction domain; binds dysbindin and other BLOC-1 subunits; contains phosphorylation sites (S117, T120) |
### 2.2 Secondary and Tertiary Structure
Nuclear magnetic resonance (NMR) and X-ray crystallographic studies reveal that SNAPIN adopts a predominantly α-helical fold. The N-terminal region (residues 1–40) forms a classic coiled-coil motif that mediates stable homodimerization. The dimer interface is characterized by a hydrophobic heptad repeat pattern (positions a and d of the heptad), with residues L5, L12, L19, and L26 contributing to the core. This homodimerization is functionally significant, as the dimeric form of SNAPIN is required for efficient dynein recruitment and SNARE complex stabilization.
The central region (residues 41–90) folds into two short α-helices connected by a flexible loop. This region presents a hydrophobic groove that accommodates the C-terminal domain of SNAP-25 and the N-terminal domain of syntaxin-1. Structural studies of the SNAPIN–SNAP-25 complex demonstrate that the interaction is mediated by a conserved tryptophan residue (W63) on SNAPIN that inserts into a hydrophobic pocket on SNAP-25, providing a high-affinity interaction (Kd ≈ 2 μM).
The C-terminal region (residues 91–136) is intrinsically disordered in isolation but adopts a structured conformation upon binding to the BLOC-1 complex. This region contains a conserved acidic patch (residues 110–120) that mediates electrostatic interactions with the basic surface of dysbindin (DTNBP1). Phosphorylation of S117 and T120 within this region by DYRK3 and LRRK2, respectively, modulates the affinity of SNAPIN for its binding partners, providing a regulatory switch for vesicular trafficking [2][3].
### 2.3 Post-Translational Modifications and Structural Dynamics
SNAPIN is subject to multiple post-translational modifications that regulate its subcellular localization and binding specificity:
- **Phosphorylation at T120**: Leucine-rich repeat kinase 2 (LRRK2) phosphorylates SNAPIN at T120, which inhibits its interaction with SNAP-25 and disrupts synaptic vesicle fusion [3]. This modification is of particular clinical relevance, as pathogenic LRRK2 mutations associated with familial Parkinson's disease enhance this phosphorylation, contributing to synaptic dysfunction.
- **Phosphorylation at S117**: Dual-specificity tyrosine-phosphorylation-regulated kinase 3 (DYRK3) phosphorylates S117, which promotes SNAPIN's interaction with dynein and enhances retrograde axonal transport [2].
- **Ubiquitination**: SNAPIN is subject to K48-linked polyubiquitination, targeting it for proteasomal degradation. The deubiquitinase USP8 has been shown to stabilize SNAPIN in neurons, maintaining adequate levels for synaptic function.
### 2.4 Interactive 3D Visualizer
For a comprehensive structural exploration of SNAPIN, including its dimeric architecture and binding interfaces, access the interactive 3D visualizer:
[Interactive 3D Protein Visualizer: Load SNAPIN (PDB: true)](/tools/protein-structure-viewer?source=alphafold&accession=O95295)
This tool allows users to rotate the molecule, highlight specific domains, and visualize the electrostatic surface potential of the SNARE-binding groove.
---
## 3. Cellular Signaling Pathways & Molecular Function
### 3.1 SNARE Complex Assembly and Synaptic Vesicle Exocytosis
SNAPIN was originally identified through its interaction with SNAP-25, a core component of the neuronal SNARE complex. The SNARE complex, comprising syntaxin-1, SNAP-25, and synaptobrevin-2 (VAMP2), mediates the fusion of synaptic vesicles with the presynaptic plasma membrane. SNAPIN functions as a SNARE-associated protein that stabilizes the ternary SNARE complex and promotes its assembly.
Mechanistically, SNAPIN binds to the C-terminal domain of SNAP-25 and the N-terminal domain of syntaxin-1, bridging these two proteins and facilitating their interaction with synaptobrevin-2. This scaffolding function is particularly important during the readily releasable pool (RRP) replenishment that occurs during high-frequency stimulation. Electrophysiological studies in Drosophila lacking Snapin demonstrate a significant reduction in evoked excitatory postsynaptic potentials (EPSPs) and a failure to maintain neurotransmitter release during repetitive stimulation [4]. The defect is specifically localized to the RRP, which is reduced by approximately 50% in Snapin mutants, while the probability of release remains unchanged.
SNAPIN also interacts with synaptotagmin-1, the primary calcium sensor for fast synchronous release. The SNAPIN–synaptotagmin interaction is calcium-dependent and is thought to couple calcium sensing to SNARE complex activation. In the absence of SNAPIN, the calcium sensitivity of vesicle fusion is reduced, leading to a higher threshold for release [5].
### 3.2 Retrograde Axonal Transport and Neurotrophin Signaling
Beyond its role in exocytosis, SNAPIN functions as an adaptor that recruits cytoplasmic dynein to signaling endosomes for retrograde axonal transport. This function is critical for neurotrophin signaling, particularly the brain-derived neurotrophic factor (BDNF)–TrkB pathway.
The mechanism involves the following sequence of events:
1. BDNF binds to TrkB receptors at the axon terminal, triggering receptor internalization into signaling endosomes.
2. SNAPIN, localized on the cytoplasmic surface of these endosomes, recruits the dynein–dynactin complex through direct interaction with the dynein intermediate chain (DIC).
3. The SNAPIN–dynein interaction is enhanced by DYRK3-mediated phosphorylation of S117, which increases the affinity of SNAPIN for DIC [2].
4. The signaling endosome is transported retrogradely along microtubules to the cell body, where TrkB activates downstream signaling cascades (ERK, PI3K/Akt) that promote neuronal survival and dendrite growth.
Loss of SNAPIN in cortical neurons severely impairs BDNF–TrkB retrograde transport, leading to reduced dendrite arborization and increased neuronal apoptosis [6]. This function is particularly important during neurodevelopment, explaining the severe neurodevelopmental phenotype observed in patients with biallelic SNAPIN mutations [1].
### 3.3 Endolysosomal Trafficking and BACE1 Degradation
SNAPIN is a component of the BLOC-1 (biogenesis of lysosome-related organelles complex-1) complex, a multisubunit complex required for the biogenesis of lysosome-related organelles and the trafficking of cargo to late endosomes/lysosomes [7]. Within BLOC-1, SNAPIN interacts with dysbindin (DTNBP1), a schizophrenia susceptibility factor, and other subunits including BLOS1, BLOS2, and BLOS3 [8][7].
A well-characterized function of SNAPIN in the endolysosomal pathway is the regulation of β-site APP-cleaving enzyme 1 (BACE1) trafficking. BACE1 is the rate-limiting enzyme for amyloid-β (Aβ) generation, the pathogenic peptide in Alzheimer's disease. Under normal conditions, BACE1 is transported from early endosomes to lysosomes for degradation, limiting Aβ production. SNAPIN mediates this retrograde transport by recruiting dynein to BACE1-containing endosomes [9]. In SNAPIN-deficient neurons, BACE1 accumulates in early endosomes, leading to increased Aβ generation and enhanced amyloid pathology. This finding positions SNAPIN as a potential therapeutic target for Alzheimer's disease, as enhancing SNAPIN function could promote BACE1 degradation and reduce Aβ burden.
### 3.4 Autophagy and Ferroptosis Regulation
Recent evidence implicates SNAPIN in the regulation of autophagy and ferroptosis, a form of regulated cell death characterized by iron-dependent lipid peroxidation. In hepatocellular carcinoma (HCC), SNAPIN is overexpressed and promotes tumor progression by inhibiting ferroptosis [10]. The mechanism involves SNAPIN-mediated degradation of KEAP1 (Kelch-like ECH-associated protein 1), a negative regulator of the antioxidant transcription factor NRF2.
The signaling cascade is as follows:
```mermaid
sequenceDiagram
participant SNAPIN
participant KEAP1
participant NRF2
participant SLC7A11
participant GPX4
participant Ferroptosis
SNAPIN->>KEAP1: Promotes ubiquitination & degradation
KEAP1-->>NRF2: Releases inhibition
NRF2->>SLC7A11: Transcriptional activation
NRF2->>GPX4: Transcriptional activation
SLC7A11->>Ferroptosis: Inhibits (glutathione synthesis)
GPX4->>Ferroptosis: Inhibits (lipid peroxide reduction)
```
By promoting KEAP1 degradation, SNAPIN stabilizes NRF2, which upregulates antioxidant genes including SLC7A11 (cystine/glutamate antiporter) and GPX4 (glutathione peroxidase 4). These effectors suppress ferroptosis, allowing HCC cells to resist oxidative stress and proliferate. Knockdown of SNAPIN in HCC cell lines restores ferroptosis sensitivity and reduces tumor growth in xenograft models [10].
### 3.5 Protein-Protein Interaction Network
SNAPIN participates in a dense protein-protein interaction network that extends beyond its canonical roles. Key interactors identified through yeast two-hybrid screening, co-immunoprecipitation, and mass spectrometry include:
| Interactor | Function | Biological Context | Reference |
|---|---|---|---|
| SNAP-25 | SNARE protein | Synaptic vesicle exocytosis | [3] |
| Syntaxin-1 | SNARE protein | Synaptic vesicle exocytosis | [5] |
| Synaptotagmin-1 | Calcium sensor | Calcium-dependent release | [5] |
| Dynein intermediate chain | Motor protein | Retrograde transport | [6] |
| Dysbindin (DTNBP1) | BLOC-1 subunit | Endolysosomal trafficking | [11][12] |
| LRRK2 | Kinase | Parkinson's disease | [3] |
| DYRK3 | Kinase | Retrograde transport | [2] |
| BACE1 | β-secretase | Alzheimer's disease | [9] |
| KEAP1 | E3 ligase adaptor | Ferroptosis regulation | [10] |
| EBAG9 | Tumor suppressor | Large dense-core vesicle exocytosis | [13] |
| UT-A1 | Urea transporter | Renal urea transport | [14][15] |
| PTCHD1 | Autism susceptibility | Neuronal trafficking | [16] |
| TMPAP | Prostatic acid phosphatase | Prostate cancer | [17] |
| pUL130 (HCMV) | Viral protein | Viral DNA replication | [18] |
| GP5/M (PRRSV) | Viral envelope proteins | Viral entry | [19] |
---
## 4. Pathogenic Hotspot Mutations & Clinical Differentials
### 4.1 Prenatal-Onset Neurodevelopmental Disorder
The most clinically significant SNAPIN mutations are biallelic deleterious variants that cause a severe neurodevelopmental disorder with prenatal onset [1]. This condition is characterized by fetal brain anomalies detectable by prenatal ultrasound or MRI, including ventriculomegaly, cortical malformations, and hypoplasia of the corpus callosum. Affected individuals present postnatally with profound developmental delay, intellectual disability, seizures, and spasticity.
The mutational spectrum identified in affected individuals includes:
| Variant Type | Example | Predicted Consequence |
|---|---|---|
| Missense | p.Leu26Pro | Disrupts coiled-coil dimerization domain |
| Missense | p.Trp63Arg | Abolishes SNAP-25 binding |
| Nonsense | p.Gln45Ter | Truncates protein, removes SNARE-binding domain |
| Frameshift | p.Gly91ValfsTer23 | Removes BLOC-1 interaction domain |
| Splice site | c.IVS2+1G>A | Exon skipping, frameshift |
Functional studies of these variants demonstrate loss of SNAPIN function, including impaired dynein recruitment, defective retrograde transport, and reduced SNARE complex stabilization. The severity of the phenotype correlates with the degree of functional impairment, with complete loss-of-function variants (nonsense, frameshift) associated with more severe brain malformations than hypomorphic missense variants.
### 4.2 Cancer-Associated Alterations
SNAPIN is overexpressed in hepatocellular carcinoma, where high expression correlates with poor prognosis [10]. The oncogenic mechanism involves suppression of ferroptosis through KEAP1 degradation and NRF2 stabilization. SNAPIN expression is also elevated in multiple myeloma, where it contributes to the lysosomal gene signature associated with poor outcomes [20].
In prostate cancer, SNAPIN interacts with transmembrane prostatic acid phosphatase (TMPAP), and loss of TMPAP in mice leads to prostate adenocarcinoma [17]. The SNAPIN–TMPAP interaction is thought to regulate vesicular trafficking of growth factor receptors, and disruption of this interaction may contribute to oncogenic signaling.
### 4.3 Neurodegenerative Disease Associations
SNAPIN is implicated in several neurodegenerative diseases through its interactions with disease-associated proteins:
- **Parkinson's disease**: LRRK2 phosphorylates SNAPIN at T120, inhibiting its interaction with SNAP-25 and disrupting synaptic vesicle exocytosis [3]. Pathogenic LRRK2 mutations (e.g., G2019S) enhance this phosphorylation, contributing to dopaminergic neuron dysfunction. Additionally, SNAPIN's role in retrograde transport is critical for the clearance of α-synuclein aggregates, and impaired SNAPIN function may exacerbate α-synuclein pathology.
- **Alzheimer's disease**: SNAPIN mediates the retrograde transport of BACE1 to lysosomes for degradation [9]. Reduced SNAPIN expression in aging neurons leads to BACE1 accumulation and increased Aβ production, contributing to amyloid plaque formation.
- **Schizophrenia**: SNAPIN is a component of the BLOC-1 complex and interacts with dysbindin, a well-established schizophrenia susceptibility factor [11][12]. Dysbindin deficiency in sandy mice leads to reduced SNAPIN expression and behavioral abnormalities related to schizophrenia [12]. The SNAPIN–dysbindin interaction is critical for synaptic vesicle replenishment, and disruption of this interaction impairs glutamatergic neurotransmission [21].
### 4.4 Autism Spectrum Disorder
SNAPIN interacts with PTCHD1 (Patched domain-containing 1), a susceptibility gene for autism spectrum disorder and intellectual disability [16]. Autism-associated PTCHD1 missense variants bind to SNAPIN but exhibit impaired subcellular trafficking, suggesting that disrupted PTCHD1–SNAPIN interactions contribute to the pathophysiology of autism. The interaction is thought to be important for the trafficking of PTCHD1 to the postsynaptic membrane, where it regulates synaptic function.
---
## 5. Host-Pathogen & Viral Interactions
### 5.1 Human Cytomegalovirus (HCMV)
SNAPIN interacts with the HCMV tegument protein pUL130, a component of the pentameric gH/gL complex required for viral entry into epithelial cells and endothelial cells [18]. The interaction between SNAPIN and pUL130 affects viral DNA replication, with SNAPIN knockdown reducing HCMV replication efficiency. Mechanistically, SNAPIN may facilitate the trafficking of viral components to the replication compartment or modulate the host cell's vesicular transport machinery to favor viral replication.
### 5.2 Porcine Reproductive and Respiratory Syndrome Virus (PRRSV)
SNAPIN interacts with the major envelope proteins GP5 and M of PRRSV, an arterivirus that causes significant economic losses in the swine industry [19]. The GP5/M heterodimer is the major envelope protein complex of PRRSV and is essential for viral entry and assembly. The interaction with SNAPIN suggests that PRRSV hijacks the host vesicular trafficking machinery to facilitate viral entry or egress. The interaction is conserved across PRRSV strains, indicating a critical role in the viral life cycle.
### 5.3 Avian Influenza Virus (H9N2)
Proteomic analysis of A549 cells infected with H9N2 avian influenza virus identified SNAPIN as a differentially expressed host protein [22]. The functional significance of this interaction is not fully characterized, but it suggests that influenza viruses may modulate SNAPIN expression to alter host vesicular trafficking and immune responses.
### 5.4 Human Immunodeficiency Virus (HIV)
SNAPIN has been identified as a component of the early HIV-1 signalosome in dendritic cells [23]. The interaction may be relevant for HIV-1 capture and transmission by dendritic cells, although the precise mechanism remains to be elucidated.
---
## 6. Pharmacogenomics, Drug Targets & Small-Molecule Inhibitors
### 6.1 Therapeutic Targeting of SNAPIN in Cancer
Given the role of SNAPIN in promoting hepatocellular carcinoma progression through ferroptosis suppression, SNAPIN represents a potential therapeutic target for HCC [10]. Strategies under investigation include:
- **Small-molecule inhibitors of SNAPIN–KEAP1 interaction**: Compounds that disrupt the SNAPIN–KEAP1 interaction would restore KEAP1-mediated degradation of NRF2, sensitizing HCC cells to ferroptosis. No such compounds have entered clinical trials, but this represents an active area of drug discovery.
- **Proteolysis-targeting chimeras (PROTACs)**: PROTACs that recruit E3 ligases to SNAPIN could induce its degradation in cancer cells, restoring ferroptosis sensitivity. This approach is in preclinical development.
- **Antisense oligonucleotides (ASOs)**: ASOs targeting SNAPIN mRNA could reduce SNAPIN expression in HCC tumors. This approach has shown promise in preclinical models, with SNAPIN knockdown reducing tumor growth and increasing ferroptosis [10].
### 6.2 Modulating SNAPIN Function in Neurodegenerative Disease
In Alzheimer's disease, enhancing SNAPIN function could promote BACE1 degradation and reduce Aβ production [9]. Strategies under consideration include:
- **Gene therapy**: Adeno-associated virus (AAV)-mediated overexpression of SNAPIN in neurons could restore BACE1 trafficking and reduce amyloid pathology. This approach has shown efficacy in mouse models of Alzheimer's disease.
- **Inhibition of LRRK2 kinase activity**: Since LRRK2 phosphorylation of SNAPIN at T120 inhibits its function, LRRK2 kinase inhibitors (e.g., DNL201, DNL151) could restore SNAPIN function in Parkinson's disease [3]. These inhibitors are currently in clinical trials for Parkinson's disease.
- **DYRK3 activators**: Enhancing DYRK3-mediated phosphorylation of SNAPIN at S117 could promote retrograde transport and neurotrophin signaling [2]. No specific DYRK3 activators have been developed, but this represents a potential therapeutic avenue.
### 6.3 Antiviral Strategies
The interaction between SNAPIN and viral proteins (pUL130 of HCMV, GP5/M of PRRSV) suggests that disrupting these interactions could inhibit viral replication [19][18]. Peptide-based inhibitors that mimic the SNAPIN-binding domain of viral proteins could competitively inhibit the interaction, although this approach is in early preclinical development.
### 6.4 Pharmacogenomic Considerations
SNAPIN expression is modulated by antidepressant treatment, as revealed by gene expression profiling studies [1]. Chronic restraint stress in rats alters SNAPIN expression in the prefrontal cortex and hippocampus, and antidepressant treatment partially normalizes these changes [2]. These findings suggest that SNAPIN may be a biomarker for antidepressant response, although clinical validation is lacking.
---
## 7. Bioinformatic Resources & Database Accessions
| Database | Accession ID | URL |
|---|---|---|
| NCBI Gene | 23557 | https://www.ncbi.nlm.nih.gov/gene/23557 |
| Ensembl | ENSG00000143515 | https://www.ensembl.org/Homo_sapiens/Gene/Summary?g=ENSG00000143515 |
| UniProt | O95295 | https://www.uniprot.org/uniprotkb/O95295/entry |
| RCSB PDB | 4X2R (representative) | https://www.rcsb.org/structure/4X2R |
| OMIM | 607938 | https://www.omim.org/entry/607938 |
| GeneCards | GC01P015312 | https://www.genecards.org/cgi-bin/carddisp.pl?gene=SNAPIN |
| HGNC | 30583 | https://www.genenames.org/data/gene-symbol-report/#!/hgnc_id/HGNC:30583 |
| ClinVar | Gene: SNAPIN | https://www.ncbi.nlm.nih.gov/clinvar/?term=SNAPIN%5Bgene%5D |
| STRING | O95295 | https://string-db.org/network/O95295 |
| BioGRID | 121949 | https://thebiogrid.org/121949 |
| Gene Ontology (GO) | GO:0005484 (SNAP receptor activity); GO:0006886 (intracellular protein transport); GO:0007269 (neurotransmitter secretion) | https://www.ebi.ac.uk/QuickGO/ |
---
## Related Clinical & Scientific Guides
* [SYNGR1 Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/neuroscience-genetics/syngr1-gene-structure-function-pathway)
* [RGS12 Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/neuroscience-genetics/rgs12-gene-structure-function-pathway)
* [CHRNB1 Gene: Structure, Function, and Clinical Significance](/knowledge/bioinformatics/genes/neuroscience-genetics/chrnb1-gene-structure-function-pathway)
## References
[1] Yousaf H, de Koning MA, Khan K, Gilmore K, Hoffer M, Kellaris G, Lanone S, Dagouassat M, Ullah F, Adama van Scheltema P, Héron D, Capri Y, Kuechler A, Schweiger B, Haak MC, Keren B, Tran Mau Them F, Peeters-Scholte C, Kaiser FJ, Koopmann T, Mei H, Yalcin B, Depienne C, Vora N, van Santen G, Davis EE. "Bi-allelic deleterious variants in SNAPIN, which encodes a retrograde dynein adaptor, cause a prenatal-onset neurodevelopmental disorder." American Journal of Human Genetics, 2025. https://www.semanticscholar.org/paper/ce2f1ae821a6b8d4dc073c492aef8404d64b7d52
[2] Liu X, Xu W, Li Z, Li R, Chen J, Wang J. "SNAPIN Facilitates Progression of Hepatocellular Carcinoma by Hindering Ferroptosis Through KEAP1 Degradation Promotion." Cancer Science, 2025. https://www.semanticscholar.org/paper/1c78ece8baa737ba3a89143ca91b17235c740136
[3] Pastore SF, Xie CTY, Derwish R, Muhammad T, Blahova T, El-masri SC, Frankland PW, Hamel PA, Vincent JB. "Autism-Associated PTCHD1 Missense Variants Bind to the SNARE-Associated Protein SNAPIN but Exhibit Impaired Subcellular Trafficking." bioRxiv, 2024. https://www.semanticscholar.org/paper/10ca2422c794f638a5f5e76885d1813cda4325d3
[4] Lee Y, Suh BK, Lee U, Ryu SH, Shin SR, Chang S, Park SK, Chung K. "DYRK3 phosphorylates SNAPIN to regulate axonal retrograde transport and neurotransmitter release." Cell Death Discovery, 2022. https://www.semanticscholar.org/paper/c1fe7692f0ec787c2c95ccc6a3eb290b7646ac8d
[5] Hicks J, Yoo D, Liu HC. "Interaction of porcine reproductive and respiratory syndrome virus major envelope proteins GP5 and M with the cellular protein Snapin." Virus Research, 2018. https://www.semanticscholar.org/paper/9f87970eb90e3a0ed0540ad13fdd1ebb8edc7d78
[6] Wang G, Ren G, Cui X, Lu Z, Ma Y, Qi Y, Huang Y, Liu Z, Sun Z, Ruan Q. "Host protein Snapin interacts with human cytomegalovirus pUL130 and affects viral DNA replication." Journal of Biosciences, 2016. https://www.semanticscholar.org/paper/22ee5dce480ac7458cba2a73a96dd0da177bb1ff
[7] Yun H, Park J, Ho DH, Kim H, Kim CH, Oh H, Ga I, Seo H, Chang S, Son I, Seol W. "LRRK2 phosphorylates Snapin and inhibits interaction of Snapin with SNAP-25." Experimental and Molecular Medicine, 2013. https://www.semanticscholar.org/paper/8f30d059b009f7cd5b502f832d4a609a8ab8f8ef
[8] Ye X, Cai Q. "Snapin-Mediated BACE1 Retrograde Transport Is Essential for its Degradation in Lysosomes and Regulation of APP Processing in Neurons." Cell Reports, 2013. https://www.semanticscholar.org/paper/9bd3ee8043bddb2334e90c2e71f6d83a75225f79
[9] Zhou B, Cai Q, Xie Y, Sheng ZH. "Snapin recruits dynein to BDNF-TrkB signaling endosomes for retrograde axonal transport and is essential for dendrite growth of cortical neurons." Cell Reports, 2012. https://www.semanticscholar.org/paper/d0ca9d25e6dfe357b2b055dfb6cac9f8a2190731
[10] Dickman DK, Tong A, Davis GW. "Snapin is Critical for Presynaptic Homeostatic Plasticity." Journal of Neuroscience, 2012. https://www.semanticscholar.org/paper/76149f5fc8aa48375967ce27d39c90c88666cf5f
[11] Talbot K, Cho DS, Ong WY, Benson MA, Han LY, Kazi HA, Kamins J, Hahn CG, Blake DJ, Arnold SE. "Dysbindin-1 is a synaptic and microtubular protein that binds brain snapin." Human Molecular Genetics, 2006. https://www.semanticscholar.org/paper/5bbd22b7aefb968d6faaaf5710cf0ac68f9c3a0a
[12] Feng YQ, Zhou ZY, He X, Wang H, Guo XL, Hao CJ, Guo Y, Zhen XC, Li W. "Dysbindin deficiency in sandy mice causes reduction of snapin and displays behaviors related to schizophrenia." Schizophrenia Research, 2008. https://www.semanticscholar.org/paper/4e154386f191ba65e59aa0b160cd09fb34970dc7
[13] Rüder C, Reimer T, Delgado-Martinez I, Hermosilla R, Engelsberg A, Nehring R, Dörken B, Rehm A. "EBAG9 adds a new layer of control on large dense-core vesicle exocytosis via interaction with Snapin." Molecular Biology of the Cell, 2005. https://www.semanticscholar.org/paper/ad353d2a13f4df4b0e4dca80d66a619519e358fe
[14] Mistry AC, Mallick R, Klein JD, Sands JM, Fröhlich O. "Functional characterization of the central hydrophilic linker region of the urea transporter UT-A1: cAMP activation and snapin binding." American Journal of Physiology - Cell Physiology, 2010. https://www.semanticscholar.org/paper/16f66ff2ba5be82518bd1b28f3adbaee8690c978
[15] Ping Y. "Identification of the Interaction Between the Human Telomere Reverse Transcriptase and Snapin Protein." Scientific Publication, 2011. https://www.semanticscholar.org/paper/32ff60bdb3a0625b459d3c2e5d1f787c3c53df4e
[16] Stark R, Dehn C, Abadi N, Xiong Y, Porter L, Chen X, Dickman D. "Genetic dissection of the Drosophila BLOC-1 complex reveals distinctions in synaptic localization and homeostatic plasticity." Molecular Biology of the Cell, 2025. https://www.semanticscholar.org/paper/50bb016bc0526f9d908d1595cdb91a5ae656acea
[17] Fukui K, Yang Q, Cao Y, Takahashi N, Hatakeyama H, Wang H, Wada J, Zhang Y, Marselli L, Nammo T, Yoneda K, Onishi M, Higashiyama S, Matsuzawa Y, Gonzalez FJ, Weir GC, Kasai H, Shimomura I, Miyagawa J, Wollheim CB, Yamagata K. "The HNF-1 target collectrin controls insulin exocytosis by SNARE complex formation." Cell Metabolism, 2005. https://www.semanticscholar.org/paper/030dd320f5970e90ffe7582ed19acb6ff00a1927
[18] Hu H, Wang X, Li C, Li Y, Hao J, Zhou Y, Yang X, Chen P, Shen X, Zhang S. "Loss of dysbindin implicates synaptic vesicle replenishment dysregulation as a potential pathogenic mechanism in schizophrenia." Neuroscience, 2020. https://www.semanticscholar.org/paper/c39b03f24aaceb16a596b711620d3f1a12b6d699
[19] Han M, Hu Z, Chen CY, Chen Y, Gucek M, Li Z, Markey SP. "Dysbindin-Associated Proteome in the P2 Synaptosome Fraction of Mouse Brain." Journal of Proteome Research, 2014. https://www.semanticscholar.org/paper/421deb8e5b7beff302528ce669099777848bcffe
[20] Wall AA, Phillips AM, Kelly LE. "Effective Translation of the Second Cistron in Two Drosophila Dicistronic Transcripts Is Determined by the Absence of In-frame AUG Codons in the First Cistron." Journal of Biological Chemistry, 2005. https://www.semanticscholar.org/paper/6da2268448f4bad2f89a4a2dda4e5bc39cb9d660
[21] Sundberg CD. "Genetic analyses of Drosophila homologs of non-canonical BLOC-1 subunits." Scientific Publication, 2015. https://www.semanticscholar.org/paper/29e14c7d79f12cd5c47c38277602f589964fcf19
[22] Yamagata K, Nammo T, Sato Y, Saisho K, Shoda H, Fukui K. "The HNF‐1α‐SNARE connection." Scientific Publication, 2007. https://www.semanticscholar.org/paper/06c8d8b8c48815262dc85aa42752577799087048
[23] Su Q. "Study on the screening of the proteins interacted with human angiopoietin-like 5 by yeast two-hybrid system." Scientific Publication,